Molecular Phenotyping of Cortical Cell Types in ALS-Related Neurodegeneration

ALS 相关神经变性中皮质细胞类型的分子表型

基本信息

  • 批准号:
    10745149
  • 负责人:
  • 金额:
    $ 42.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-06-01 至 2027-05-31
  • 项目状态:
    未结题

项目摘要

The combined degeneration of both “lower” motor neurons in the brainstem and spinal cord and “upper” motor neurons (UMNs) in the cerebral cortex is an important hallmark of ALS. Almost all cases of ALS are eventually fatal, and the rapid progression of the disease makes it particularly terrible, with over 80% of patients dying within five years of diagnosis. No cure exists for ALS and the only available treatments slow disease progression by merely a few months. Therefore, a great need exists for more effective and specific therapies that can stop or even reverse neurodegeneration. Innovation for such therapies will only arise from a better understanding of the molecular mechanisms underlying the pathological process, especially since most genes linked to ALS are ubiquitously expressed yet only specific populations of cells degenerate. Understanding why certain cells are uniquely vulnerable and mapping cell type specific pathways that are dysregulated during disease are crucial milestones. This has posed a considerable challenge for the spinal cord projecting UMNs since they are difficult to distinguish from other pyramidal cell types and are therefore often overlooked in preclinical studies. Because of this, the basis for their selective vulnerability to ALS-causing mutations has remained a mystery. The proposed study aims to overcome this by building on recent work that identified two highly similar yet molecularly distinct subpopulations of projection neurons in layer 5b of motor cortex, where UMNs reside. These populations have overlapping projections to pons, but non-overlapping projections to the spinal cord or thalamus. Examining these cells in preclinical models of ALS revealed that the corticospinal projecting neurons (CSTNs) were vulnerable to degeneration, while the corticopontine-only population (CPN) did not degenerate. The selective vulnerability of the CSTNs was likely due to dysregulation of mitochondrial function since a dramatic upregulation of genes related to oxidative phosphorylation and mitophagy was observed at symptomatic stages of disease. Aim 1 of this grant will employ an integrative multi-omics approach to address whether differences in the properties of mitochondria between CSTNs and CPNs drive differential responses to disease using a novel, viral-based strategy to isolate cell type specific mitochondria during disease progression in two preclinical ALS models, SOD1G93A and FUSP525L. Aim 2 focuses on dissecting the cellular role of identified candidate genes that are enriched in CSTNs and cell type-specific bioenergetic pathways, linking them to mitochondrial function and disease vulnerability. To increase the translational significance of this work, Aim 3 will leverage novel markers for CSTNs and CPNs for a detailed anatomical analysis of postmortem tissue from ALS patients to perform transcriptional profiling on cell type specific nuclei isolated by fluorescence activated nuclear sorting (FANS) from postmortem patient tissue. Results from this study will yield novel mechanisms underlying selective vulnerability of UMNs in ALS.
脑干脊髓“下”运动神经元和“上”运动神经元的联合变性 大脑皮层运动神经元(UMN)是ALS的重要标志。几乎所有的ALS病例都是 最终是致命的,这种疾病的快速发展使其特别可怕,超过80%的 患者在确诊后五年内死亡。肌萎缩侧索硬化症没有治愈方法,唯一可用的治疗方法是缓慢的 疾病进展只有几个月。因此,迫切需要更有效和更具体的 可以阻止甚至逆转神经退化的疗法。这种疗法的创新只会产生于 更好地理解病理过程背后的分子机制,特别是因为大多数 与肌萎缩侧索硬化症相关的基因普遍表达,但只有特定的细胞群退化。 了解为什么某些细胞是唯一脆弱的,并映射特定类型的细胞路径 疾病期间的失调是关键的里程碑。这给脊椎带来了相当大的挑战 脊髓突起的UMN,因为它们很难与其他锥体细胞类型区分开来,因此 在临床前研究中经常被忽视。正因为如此,他们对导致ALS的选择性易感性的基础 基因突变一直是个谜。 这项拟议的研究旨在通过在最近的工作基础上发现两个高度相似的 然而,UMN所在的运动皮质5b层的投射神经元亚群在分子上是不同的。 这些人群对脑桥有重叠的投射,但对脊髓或 丘脑。在ALS的临床前模型中检查这些细胞发现,皮质脊髓投射神经元 (CSTN)容易退化,而仅皮质桥脑(CPN)种群不退化。 CSTN的选择性脆弱性可能是由于线粒体功能失调所致 与氧化磷酸化和有丝分裂相关的基因显著上调 疾病的症状阶段。这笔赠款的目标1将采用综合多组学方法来解决 CSTN和CPN之间线粒体特性的差异是否会导致对 在疾病进展过程中使用一种新的基于病毒的策略来分离细胞类型特定的线粒体 在两个临床前ALS模型中,SOD1G93A和FUSP525L。目标2侧重于剖析细胞中的 确定了富含CSTN和细胞类型特定的生物能量途径的候选基因,将 它们与线粒体功能和疾病脆弱性有关。为了增加这部作品的翻译意义, AIM 3将利用CSTN和CPN的新标记对身体进行详细的解剖分析 肌萎缩侧索硬化症患者组织对荧光分离的细胞型特异性核进行转录图谱分析 激活了死后患者组织的核分类(FANS)。这项研究的结果将产生新的 肌萎缩侧索硬化症中UMNS选择性易损性的潜在机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric F Schmidt其他文献

Eric F Schmidt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric F Schmidt', 18)}}的其他基金

Phenotyping Corticospinal Axon Degeneration in Preclinical ALS Models.
临床前 ALS 模型中皮质脊髓轴突变性的表型分析。
  • 批准号:
    10732637
  • 财政年份:
    2023
  • 资助金额:
    $ 42.38万
  • 项目类别:
Molecular phenotyping of cortical cell types in multiple rodent models of ALS
多种 ALS 啮齿动物模型中皮质细胞类型的分子表型
  • 批准号:
    9258507
  • 财政年份:
    2016
  • 资助金额:
    $ 42.38万
  • 项目类别:
Molecular Phenotyping of Cortical Cell Types in ALS Related Neurodegeneration
ALS 相关神经变性中皮质细胞类型的分子表型
  • 批准号:
    10592732
  • 财政年份:
    2016
  • 资助金额:
    $ 42.38万
  • 项目类别:
Molecular phenotyping of cortical cell types in multiple rodent models of ALS
多种 ALS 啮齿动物模型中皮质细胞类型的分子表型
  • 批准号:
    9906956
  • 财政年份:
    2016
  • 资助金额:
    $ 42.38万
  • 项目类别:

相似海外基金

Whole Genome Sequencing to identify novel loci in French Canadian ALS patients
全基因组测序识别法裔加拿大 ALS 患者的新基因座
  • 批准号:
    387259
  • 财政年份:
    2017
  • 资助金额:
    $ 42.38万
  • 项目类别:
    Studentship Programs
Elucidation of the optimal period of PAP therapy aiming at oral ingestion by ALS patients.
阐明针对 ALS 患者口服摄入的 PAP 治疗的最佳时期。
  • 批准号:
    19K20753
  • 财政年份:
    2016
  • 资助金额:
    $ 42.38万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
The effect of TNF-alpha on microglial induced hyperexcitation in cortical neurons of ALS patients
TNF-α对ALS患者皮质神经元小胶质细胞过度兴奋的影响
  • 批准号:
    367192
  • 财政年份:
    2016
  • 资助金额:
    $ 42.38万
  • 项目类别:
    Studentship Programs
Study of a communication support system for ALS patients based on changes in cerebral ongoing activity
基于大脑持续活动变化的ALS患者沟通支持系统研究
  • 批准号:
    15K12605
  • 财政年份:
    2015
  • 资助金额:
    $ 42.38万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Comprehensive genetic analysis of ALS-related genes in Japanese sporadic ALS patients
日本散发性ALS患者ALS相关基因综合遗传分析
  • 批准号:
    15K19485
  • 财政年份:
    2015
  • 资助金额:
    $ 42.38万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
ALS4 mice show TDP-43 protein mislocalization in motor neurons characteristic of sporadic ALS patients; suggesting this model is likely to reveal important patho-mechanistic disease insights
ALS4 小鼠在运动神经元中显示 TDP-43 蛋白错误定位,这是散发性 ALS 患者的特征;
  • 批准号:
    nhmrc : 1045520
  • 财政年份:
    2013
  • 资助金额:
    $ 42.38万
  • 项目类别:
    NHMRC Project Grants
Study of restoration process of the living environments of bereaved families that had undertaken long-term at-home care for ALS patients
长期居家护理ALS患者家属生活环境恢复过程研究
  • 批准号:
    24760510
  • 财政年份:
    2012
  • 资助金额:
    $ 42.38万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Microarray analysis in spinal cords of sporadic ALS patients with cell-type specific transcriptome
散发性 ALS 患者脊髓中细胞类型特异性转录组的微阵列分析
  • 批准号:
    24591259
  • 财政年份:
    2012
  • 资助金额:
    $ 42.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A pathological study of impaired cytoplasmic-nuclear transport impairment infamilial ALS patients harboring FUS mutatio
携带FUS突变的家族性ALS患者细胞质-核转运受损的病理学研究
  • 批准号:
    23790997
  • 财政年份:
    2011
  • 资助金额:
    $ 42.38万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
MODEL FOR THE PROMOTION OF A BARRIER-FREE MIND IN THE FAMILY CAREGIVER OF ALS PATIENTS
促进 ALS 患者家庭护理人员无障碍心态的模型
  • 批准号:
    23593266
  • 财政年份:
    2011
  • 资助金额:
    $ 42.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了